• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

• Catalysts and Inorganic Chemicals Inorganic Compounds Homogeneous non-metal compounds Homogeneous other non-metal compounds

Introduction to 2-CYANOPYRIDINE-D4 (CAS No. 1219795-17-1)

2-CYANOPYRIDINE-D4, with the chemical formula C?H?ND, is a deuterated derivative of 2-cyanopyridine, a heterocyclic compound featuring a cyano group attached to a pyridine ring. This compound has garnered significant attention in the field of pharmaceutical research due to its unique structural properties and potential applications in drug development. The deuterated version, specifically, is utilized in various scientific studies to enhance the metabolic stability and analytical precision of biochemical assays.

The CAS No. 1219795-17-1 identifier ensures precise chemical classification and tracking within the global scientific community. As a deuterated analog, 2-CYANOPYRIDINE-D4 is particularly valuable in metabolic studies, where the substitution of hydrogen atoms with deuterium (2H) helps in distinguishing endogenous compounds from those administered exogenously. This property is instrumental in understanding drug metabolism and pharmacokinetics, making it a cornerstone in modern medicinal chemistry.

In recent years, the demand for labeled compounds like 2-CYANOPYRIDINE-D4 has surged due to advancements in mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy techniques. These methods rely heavily on isotopically labeled compounds to achieve higher resolution and sensitivity in analytical processes. The deuterated version of 2-cyanopyridine is particularly useful in NMR studies, where it aids in elucidating molecular structures with greater accuracy.

The pyridine ring is a versatile scaffold in pharmaceutical chemistry, serving as a core structure for numerous bioactive molecules. Its ability to interact with biological targets makes it an attractive motif for drug design. The introduction of a cyano group at the 2-position enhances the electrophilicity of the ring, facilitating further functionalization and derivatization. This feature is exploited in the synthesis of complex molecules targeting various therapeutic areas, including oncology, neurology, and infectious diseases.

Recent research has highlighted the role of 2-CYANOPYRIDINE-D4 in developing novel antiviral agents. The cyano-substituted pyridine derivative has shown promising activity against certain viral proteases, making it a potential lead compound for further optimization. Studies have demonstrated that the deuterated analog exhibits improved binding affinity and reduced metabolic clearance compared to its non-deuterated counterpart. This underscores the significance of isotopic labeling in enhancing drug candidate properties.

The pharmaceutical industry has also explored 2-CYANOPYRIDINE-D4 as an intermediate in synthesizing kinase inhibitors. Kinases are enzymes involved in cell signaling pathways, and their dysregulation is implicated in various diseases, particularly cancer. By leveraging the unique reactivity of the cyano group and the deuterated label, researchers have been able to design more potent and selective kinase inhibitors. These efforts have led to several preclinical candidates that are currently undergoing further evaluation.

Another emerging application of 2-CYANOPYRIDINE-D4 is in the field of agrochemicals. The pyridine scaffold is commonly found in herbicides and pesticides due to its ability to interact with biological targets in plants and pests. The cyano group introduces additional reactivity, enabling the synthesis of compounds with enhanced efficacy and environmental safety profiles. Recent studies have shown that derivatives of 2-cyanopyridine exhibit strong herbicidal activity while minimizing ecological impact.

The synthesis of 2-CYANOPYRIDINE-D4 involves multi-step organic reactions, often starting from commercially available pyridine derivatives. Advanced catalytic methods have been developed to improve yield and purity while reducing environmental footprint. These synthetic strategies are critical for ensuring that researchers have access to high-quality starting materials for their investigations.

In conclusion, 2-CYANOPYRIDINE-D4 (CAS No. 1219795-17-1) is a multifaceted compound with broad applications across pharmaceuticals, agrochemicals, and analytical chemistry. Its unique structural features make it an invaluable tool for researchers seeking to develop novel therapeutics and improve analytical methodologies. As scientific understanding continues to evolve, the role of labeled compounds like 2-CYANOPYRIDINE-D4 will undoubtedly expand, driving innovation in multiple domains.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)